Gupta Ashoo
VP, Finance and Controller
Gupta Ashoo has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 24, 2026.
On the most recent filing, Gupta Ashoo is listed as VP, Finance and Controller at 4D Molecular Therapeutics, Inc. Inside the rolling window, Gupta Ashoo reported no open-market purchases and 2 open-market sales totaling $7K in FDMT. The largest disclosed transaction in the window is a sale of 389 FDMT shares on Dec 20, 2025, worth $3K.
Companies traded
Other insiders at FDMT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gupta Ashoo made?
Gupta Ashoo has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Gupta Ashoo trade?
Gupta Ashoo has filed SEC Form 4 disclosures for 1 company, including FDMT.
When was Gupta Ashoo's most recent SEC Form 4 filing?
Gupta Ashoo's most recent SEC Form 4 filing on Tracefour is dated Mar 24, 2026.
What is Gupta Ashoo's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gupta Ashoo is listed as VP, Finance and Controller.
What is Gupta Ashoo's total buy and sell value in the current window?
Inside the rolling retention window, Gupta Ashoo bought $0 and sold $7K based on SEC Form 4 filings.
What was Gupta Ashoo's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 389 FDMT shares on 2025-12-20, worth $3K, per SEC Form 4 filings.